Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The hemophilia treatment drugs market is experiencing entry of a large number of new drugs in the market. Few of them have already arrived and other long lasting clotting factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II study of hemophilia medicine ‘Emicizumab’ by Roche has demonstrated promising results regarding safety and prophylactic efficiency in people with severe hemophilia A. Another example is of ‘Eloctate’ for type A and ‘Aprolix’ for type B hemophilia, respectively. These two newly arrived biogen products are opposed to commonly prescribe course of three infusions per week as they are longer-acting than traditional treatments and require only one to two infusions per week, due to their new mechanism of action.
With increasing attention on prophylactic treatment, the market for hemophilia drugs is estimated to have a positive outlook over the coming years. The prophylactic treatment approach prevents spontaneous bleeding episodes, significantly improves the quality of life in terms of physical activities, and maintains the level of clotting factors above a baseline. According to the studies conducted by the US National Library of Medicine determined that the savings on prophylactic treatment be approximately USD 8,312 to USD 17,675 per bleeding episode in a person. Moreover, this line of treatment reduces joint damage and suffering from pain. Several of such long-acting therapeutics are under development and expected to be launched over the next four years. The shift in preference for prophylactic treatment due to its advantages will drive this market’s growth over the forecast period.The Americas led the global hemophilia drugs market in 2017 and is expected to continue its dominance until the end of 2023. The Americas have the highest revenue share in the global market with the US contributing to the majority of this revenue. Several countries in the region have introduced health care reforms which are having a positive impact on the market growth. Moreover, healthcare reforms in the US have also helped reduce the cost of pharmaceutical drugs, increased access to healthcare, and improved the overall quality of healthcare. These healthcare reforms are likely to have a positive impact on healthcare insurance and also reduce hospital stay and overall medical expenses, which will boost this market’s growth in the region.
This report elaborates on the current development of the Hemophilia Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Pfizer
Grifols
Bayer
Catalyst Biosciences
F Hoffmann-La Roche
Spark Therapeutics
Dimension Therapeutics
Sangamo Biosciences
Baxalta
CSL Behring
Alnylam Pharmaceuticals
Swedish Orphan Biovitrum
Octapharma
BioMarin
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Hemophilia A
Inhibitors
Hemophilia B
Von Willebrand Disease
Application:
Recombinant Therapies
Plasma-Derived Therapies
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Hemophilia Drugs Industry Overview
-
1.1.1 Hemophilia Drugs Market Scope and Market Segments
-
1.1.2 Hemophilia Drugs Industry Characteristics
-
1.1.3 Global and China Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Hemophilia Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Hemophilia Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Hemophilia A
-
1.2.2 Inhibitors
-
1.2.3 Hemophilia B
-
1.2.4 Von Willebrand Disease
-
1.3 Global Hemophilia Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Recombinant Therapies
-
1.3.2 Plasma-Derived Therapies
-
1.4 Market Analysis by Region
-
1.4.1 North America Hemophilia Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Hemophilia Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Hemophilia Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Hemophilia Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Hemophilia Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Hemophilia Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Hemophilia Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Hemophilia Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Hemophilia Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Hemophilia Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Hemophilia Drugs Industry PEST Analysis
-
2.3 Hemophilia Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Hemophilia Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Hemophilia Drugs Industry
Chapter 3 Global and China Hemophilia Drugs Market, by Manufacturer
-
3.1 Global and China Hemophilia Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Hemophilia Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Hemophilia Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Hemophilia Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Hemophilia Drugs Market Top 3 Players
Chapter 4 Global and China Hemophilia Drugs Market, by Type (2017-2028)
-
4.1 Hemophilia Drugs Market Trend, by Type
-
4.2 Global Hemophilia Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Hemophilia Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Hemophilia Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Hemophilia Drugs Price Trend, by Type (2017-2028)
-
4.3 China Hemophilia Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Hemophilia Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Hemophilia Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Hemophilia Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Hemophilia Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Hemophilia Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Hemophilia Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Hemophilia Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Hemophilia Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Hemophilia Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Hemophilia Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Hemophilia Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Hemophilia Drugs Market Analysis
-
7.1 North America Hemophilia Drugs Market, by Type
-
7.2 North America Hemophilia Drugs Market, by Application
-
7.3 North America Hemophilia Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Hemophilia Drugs Market Analysis
-
8.1 Europe Hemophilia Drugs Market, by Type
-
8.2 Europe Hemophilia Drugs Market, by Application
-
8.3 Europe Hemophilia Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Hemophilia Drugs Market Analysis
-
9.1 APAC Hemophilia Drugs Market, by Type
-
9.2 APAC Hemophilia Drugs Market, by Application
-
9.3 APAC Hemophilia Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Hemophilia Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Hemophilia Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Hemophilia Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Hemophilia Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Hemophilia Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Hemophilia Drugs Company Profiles
-
11.1 Pfizer
-
11.1.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Pfizer Hemophilia Drugs Product Profiles, Application and Specification
-
11.1.3 Pfizer Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Grifols
-
11.2.1 Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Grifols Hemophilia Drugs Product Profiles, Application and Specification
-
11.2.3 Grifols Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Bayer
-
11.3.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Bayer Hemophilia Drugs Product Profiles, Application and Specification
-
11.3.3 Bayer Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Catalyst Biosciences
-
11.4.1 Catalyst Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Catalyst Biosciences Hemophilia Drugs Product Profiles, Application and Specification
-
11.4.3 Catalyst Biosciences Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 F Hoffmann-La Roche
-
11.5.1 F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 F Hoffmann-La Roche Hemophilia Drugs Product Profiles, Application and Specification
-
11.5.3 F Hoffmann-La Roche Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Spark Therapeutics
-
11.6.1 Spark Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Spark Therapeutics Hemophilia Drugs Product Profiles, Application and Specification
-
11.6.3 Spark Therapeutics Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Dimension Therapeutics
-
11.7.1 Dimension Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Dimension Therapeutics Hemophilia Drugs Product Profiles, Application and Specification
-
11.7.3 Dimension Therapeutics Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Sangamo Biosciences
-
11.8.1 Sangamo Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Sangamo Biosciences Hemophilia Drugs Product Profiles, Application and Specification
-
11.8.3 Sangamo Biosciences Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Baxalta
-
11.9.1 Baxalta Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Baxalta Hemophilia Drugs Product Profiles, Application and Specification
-
11.9.3 Baxalta Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 CSL Behring
-
11.10.1 CSL Behring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 CSL Behring Hemophilia Drugs Product Profiles, Application and Specification
-
11.10.3 CSL Behring Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Alnylam Pharmaceuticals
-
11.11.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Alnylam Pharmaceuticals Hemophilia Drugs Product Profiles, Application and Specification
-
11.11.3 Alnylam Pharmaceuticals Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Swedish Orphan Biovitrum
-
11.12.1 Swedish Orphan Biovitrum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Swedish Orphan Biovitrum Hemophilia Drugs Product Profiles, Application and Specification
-
11.12.3 Swedish Orphan Biovitrum Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Octapharma
-
11.13.1 Octapharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Octapharma Hemophilia Drugs Product Profiles, Application and Specification
-
11.13.3 Octapharma Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 BioMarin
-
11.14.1 BioMarin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 BioMarin Hemophilia Drugs Product Profiles, Application and Specification
-
11.14.3 BioMarin Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Hemophilia Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Hemophilia Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Hemophilia Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Hemophilia Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Hemophilia Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Hemophilia Drugs Market Size and Growth Rate of Hemophilia A (2017-2028)
-
Figure Global Hemophilia Drugs Market Size and Growth Rate of Inhibitors (2017-2028)
-
Figure Global Hemophilia Drugs Market Size and Growth Rate of Hemophilia B (2017-2028)
-
Figure Global Hemophilia Drugs Market Size and Growth Rate of Von Willebrand Disease (2017-2028)
-
Figure Global Hemophilia Drugs Market Size and Growth Rate of Recombinant Therapies (2017-2028)
-
Figure Global Hemophilia Drugs Market Size and Growth Rate of Plasma-Derived Therapies (2017-2028)
-
Figure North America Hemophilia Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Hemophilia Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Hemophilia Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Hemophilia Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Hemophilia Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Hemophilia Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Hemophilia Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Hemophilia Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Hemophilia Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Hemophilia Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Hemophilia Drugs Market Share, by Manufacturer in 2022
-
Table Global Hemophilia Drugs Sales Volume, by Type (2017-2028)
-
Table Global Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Hemophilia Drugs Sales Value, by Type (2017-2028)
-
Table Global Hemophilia Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Hemophilia Drugs Price Trend, by Type (2017-2028)
-
Table China Hemophilia Drugs Sales Volume, by Type (2017-2028)
-
Table China Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Hemophilia Drugs Sales Value, by Type (2017-2028)
-
Table China Hemophilia Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Hemophilia Drugs Price Trend, by Type (2017-2028)
-
Table Global Hemophilia Drugs Sales Volume, by Application (2017-2028)
-
Table Global Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Hemophilia Drugs Sales Value, by Application (2017-2028)
-
Table Global Hemophilia Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Hemophilia Drugs Sales Value Share, by Application (2017-2028)
-
Table China Hemophilia Drugs Sales Volume, by Application (2017-2028)
-
Table China Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Hemophilia Drugs Sales Value, by Application (2017-2028)
-
Table China Hemophilia Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Hemophilia Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Hemophilia Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Hemophilia Drugs Sales Volume, by Type (2017-2028)
-
Table North America Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Hemophilia Drugs Sales Volume, by Application (2017-2028)
-
Table North America Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Hemophilia Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Hemophilia Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Hemophilia Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Hemophilia Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Hemophilia Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Hemophilia Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Hemophilia Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Hemophilia Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Hemophilia Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Hemophilia Drugs Sales Value and Growth Rate (2017-2028)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Grifols Product Profiles, Application and Specification
-
Table Grifols Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Catalyst Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Catalyst Biosciences Product Profiles, Application and Specification
-
Table Catalyst Biosciences Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table F Hoffmann-La Roche Product Profiles, Application and Specification
-
Table F Hoffmann-La Roche Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Spark Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Spark Therapeutics Product Profiles, Application and Specification
-
Table Spark Therapeutics Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dimension Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dimension Therapeutics Product Profiles, Application and Specification
-
Table Dimension Therapeutics Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sangamo Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sangamo Biosciences Product Profiles, Application and Specification
-
Table Sangamo Biosciences Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Baxalta Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Baxalta Product Profiles, Application and Specification
-
Table Baxalta Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CSL Behring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CSL Behring Product Profiles, Application and Specification
-
Table CSL Behring Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Alnylam Pharmaceuticals Product Profiles, Application and Specification
-
Table Alnylam Pharmaceuticals Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Swedish Orphan Biovitrum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Swedish Orphan Biovitrum Product Profiles, Application and Specification
-
Table Swedish Orphan Biovitrum Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Octapharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Octapharma Product Profiles, Application and Specification
-
Table Octapharma Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BioMarin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BioMarin Product Profiles, Application and Specification
-
Table BioMarin Hemophilia Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
